Efficacy of Molecular-targeted Agents in Vertebral Metastasis Management in Non-small Cell Lung Cancer
Modern systemic therapies, particularly MTAs, present significant efficacy in controlling vertebral metastases in patients with NSCLC without prior systemic therapy. Deferring local treatments may be feasible in patients without prior systemic therapy, whereas those who develop vertebral metastases after treatment may require additional treatment.
Authors
- Hideya Yamazaki (ORCID: https://orcid.org/0000-0001-7508-7217)
- Ken Yoshida (ORCID: https://orcid.org/0000-0002-5351-3227)
- Yusuke Anetai (ORCID: https://orcid.org/0000-0002-2284-7582)
- Kazuki Hirota
- Midori Yui
- Hideki Takegawa (ORCID: https://orcid.org/0000-0002-3205-3487)
- Asami Yoshida (ORCID: https://orcid.org/0000-0001-7045-3708)
- Noboru Tanigawa (ORCID: https://orcid.org/0000-0002-7283-3381)
- Yuhei Koike (ORCID: https://orcid.org/0000-0003-3963-4257)
- Takayasu Kurata (ORCID: https://orcid.org/0000-0003-4123-3567)
- Masaaki Paku (ORCID: https://orcid.org/0000-0002-7564-7293)
- Satoaki Nakamura (ORCID: https://orcid.org/0000-0001-5721-3734)
- Ken Shigeyama
- Ken‐ichi Ueda
Institutions
- Kansai Medical University (JP)
- Kyoto Prefectural University of Medicine (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21873/anticanres.17498
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00